Trials / Completed
CompletedNCT01484951
AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure
Assessing the Safety and Efficacy of Switching to AZARGA® (Brinzolamide/Timolol Fixed Combination) as Replacement Therapy in Patients With Uncontrolled Intraocular Pressure in Taiwan
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to assess the safety and efficacy of switching to Azarga from prior pharmacotherapy in patients with open-angle glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brinzolamide 1% and timolol 0.5% fixed combination eye drops |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-12-05
- Last updated
- 2013-05-01
- Results posted
- 2013-04-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01484951. Inclusion in this directory is not an endorsement.